| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | tyrosine-protein kinase abl1 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | rac-alpha serine/threonine-protein kinase | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | g1/s-specific cyclin-d1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | cyclin-dependent kinase 4 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | cyclin-dependent kinase 9 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | checkpoint kinase-1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | casein kinase ii alpha | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | glycogen synthase kinase-3 beta | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | extracellular signal-regulated kinase 2 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | stress-activated protein kinase 2a | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | prkaca messenger rna | NA | Patented-recorded target | TTD | NA | NA | investigative | unknown |
| 4-[(3,5-diamino-1h-pyrazol-4-yl)diazenyl]phenol | ribosomal protein s6 kinase beta-1 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| click here to return to the previous page | ||||||||